Nouveau BioSciences
PrivateLast Round
Strategic
Jan 13, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nouveau BioSciences is a biotechnology company that develops targeted nanomedicines and oncology therapeutics using a proprietary platform that integrates synthetic lethality, genomics, and computational biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nouveau BioSciences Comparables
Compare Nouveau BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duo Oncology | 81% | |
| Peptinovo Biopharma | 80% | |
| Stradefy Biosciences | 79% |
Nouveau BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 13, 2026 |
Nouveau BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CanceRx | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Raised a strategic round led by CanceRx.
Recent news
Latest coverage and updates
- is_developingJul 15, 2026
Nouveau BioSciences, Inc. is developing precision targeted drugs tailored for very specific types of cancer on Jul 15th '26.
Nouveau BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nouveau BioSciences's valuation, stock price, and market status.
Is Nouveau BioSciences a public or private company?
Nouveau BioSciences is a private company.
What is the current stock price of Nouveau BioSciences?
Nouveau BioSciences is a private company with no public stock price. No recent secondary market data is available.
How much is Nouveau BioSciences worth (valuation)?
Valuation information for Nouveau BioSciences is not publicly available.
Can I buy Nouveau BioSciences stock?
Nouveau BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nouveau BioSciences's last funding round?
Nouveau BioSciences's most recent funding round was Strategic on January 13, 2026.
Who are the main investors in Nouveau BioSciences?
Key investors in Nouveau BioSciences include CanceRx.
Will Nouveau BioSciences IPO soon?
No public IPO plans have been announced for Nouveau BioSciences.
How can I track Nouveau BioSciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nouveau BioSciences's secondary market activity and sign up for updates.